Services
Diagnoses
Procedures
A prostate cancer diagnosis can feel overwhelming, but many effective treatment options are available. Advances in medical technology and cancer research have made it possible to tailor treatment plans to each individual patient. The best approach depends on several factors, including the stage and aggressiveness of the cancer, PSA levels, the patient’s age and overall health, and personal preferences regarding potential side effects and recovery time.
Some prostate cancers grow slowly and may not require immediate treatment, while others may need a more aggressive approach. A urologist or cancer specialist will review your diagnosis and help guide you through the options to determine the most appropriate treatment plan.
For men with low-risk, slow-growing prostate cancer, active surveillance may be recommended. Instead of beginning treatment right away, doctors closely monitor the cancer to ensure it is not progressing.
Active surveillance typically includes:
Regular PSA (prostate-specific antigen) blood tests
Digital rectal exams (DRE)
Periodic prostate biopsies or imaging studies
The goal is to avoid or delay treatment—and the potential side effects associated with surgery or radiation—while still monitoring the cancer carefully. If testing shows that the cancer is becoming more aggressive, treatment can begin at that time.
A prostatectomy is the surgical removal of the prostate gland and, in some cases, surrounding tissues. This treatment is often recommended for men with localized prostate cancer who are healthy enough for surgery and have a longer life expectancy.
Prostatectomy may be performed using:
Traditional open surgery
Laparoscopic surgery
Robotic-assisted surgery
Robotic-assisted techniques have become increasingly common because they allow surgeons to operate with enhanced precision using small incisions. The goal of surgery is to remove the cancer completely while preserving nearby structures when possible.
Radiation therapy uses high-energy beams or radioactive materials to destroy cancer cells. It can be used as a primary treatment for prostate cancer or after surgery if there is concern that cancer cells may remain.
There are two main types of radiation therapy used for prostate cancer:
External Beam Radiation Therapy (EBRT)Radiation is delivered from a machine outside the body and directed precisely at the prostate.
BrachytherapySmall radioactive seeds are implanted directly into the prostate, where they release radiation over time to destroy cancer cells.
Radiation therapy is a highly effective treatment option for many men with localized or locally advanced prostate cancer.
Hormone therapy, also called androgen deprivation therapy (ADT), works by lowering or blocking the male hormones—primarily testosterone—that prostate cancer cells rely on to grow.
Hormone therapy may be used:
In combination with radiation therapy
For cancers that have spread beyond the prostate
When prostate cancer returns after initial treatment
By reducing hormone levels, this therapy can slow the growth of prostate cancer and help control the disease.
Chemotherapy uses medications that circulate throughout the body to destroy rapidly dividing cancer cells. It is most commonly used for advanced prostate cancer that has spread outside the prostate gland or no longer responds to hormone therapy.
While chemotherapy does not usually cure advanced prostate cancer, it can help:
Slow cancer progression
Reduce symptoms
Improve quality of life
Immunotherapy is an emerging treatment that helps the body’s immune system recognize and attack cancer cells. One example is sipuleucel-T (Provenge®), an FDA-approved therapy used for certain patients with advanced prostate cancer.
This treatment works by stimulating the immune system to identify prostate cancer cells and mount a targeted response against them.
Targeted therapies focus on specific genetic mutations or biological processes that allow cancer cells to grow. These treatments are designed to attack cancer cells more precisely while limiting damage to healthy tissue.
For example, PARP inhibitors may be used in patients whose prostate cancer is associated with inherited genetic mutations such as BRCA1 or BRCA2. Genetic testing may help determine whether targeted therapies are an appropriate option.
Every prostate cancer diagnosis is unique, and treatment decisions should be made in close consultation with your healthcare team. Factors such as cancer stage, tumor aggressiveness, overall health, potential side effects, and personal priorities all play an important role in determining the best course of action.
Discussing your options with a qualified specialist can help you understand the benefits and risks of each approach and ensure you receive the most effective and personalized care possible.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
These cookies are needed for adding comments on this website.
Google Tag Manager simplifies the management of marketing tags on your website without code changes.
You can find more information in our Cookie Policy and Privacy Policy.